Healthcare resource utilisation and costs associated with a heart failure diagnosis : A retrospective, population-based cohort study in Sweden
| العنوان: | Healthcare resource utilisation and costs associated with a heart failure diagnosis : A retrospective, population-based cohort study in Sweden |
|---|---|
| المؤلفون: | Stina Johansson, A.F Fonseca, Gerhard Wikström, Kurt Boman, Vincent Heller, Jan Stålhammar, Mona Olofsson, Madlaina Costa-Scharplatz, M. Tornblom, Krister Lindmark |
| المصدر: | BMJ Open BMJ Open, Vol 11, Iss 10 (2021) |
| بيانات النشر: | Umeå universitet, Avdelningen för medicin, 2021. |
| سنة النشر: | 2021 |
| مصطلحات موضوعية: | Adult, Male, medicine.medical_specialty, Adolescent, Population, heart failure, Logistic regression, Secondary Care, Cohort Studies, Health Economics, Internal medicine, adult cardiology, Health care, medicine, Humans, health economics, Cardiac and Cardiovascular Systems, education, Retrospective Studies, Heart Failure, Sweden, education.field_of_study, Ejection fraction, Health economics, Kardiologi, business.industry, Medical record, Stroke Volume, General Medicine, Cohort, Medicine, business, Cohort study |
| الوصف: | ObjectivesTo examine healthcare resource use (HRU) and costs among heart failure (HF) patients using population data from Sweden.DesignRetrospective, non-interventional cohort study.SettingTwo cohorts were identified from linked national health registers (cohort 1, 2005–2014) and electronic medical records (cohort 2, 2010–2012; primary/secondary care patients from Uppsala and Västerbotten).ParticipantsPatients (aged ≥18 years) with primary or secondary diagnoses of HF (≥2 International Classification of Diseases and Related Health Problems, 10th revision classification) during the identification period of January 2005 to March 2015 were included.Outcome measuresHRU across the HF phenotypes was assessed with logistic regression. Costs were estimated based on diagnosis-related group codes and general price lists.ResultsTotal annual costs of secondary care of prevalent HF increased from SEK 6.23 (€0.60) to 8.86 (€0.85) billion between 2005 and 2014. Of 4648 incident patients, HF phenotype was known for 1715: reduced ejection fraction (HFrEF): 64.5%, preserved ejection fraction (HFpEF): 35.5%. Within 1 year of HF diagnosis, the proportion of patients hospitalised was only marginally higher for HFrEF versus HFpEF (all-cause (95% CI): 64.7% (60.8 to 68.4) vs 63.7% (60.8 to 66.5), HR 0.91, p=0.14; cardiovascular disease related (95% CI): 61.1% (57.1 to 64.8) vs 60.9% (58.0 to 63.7), HR 0.93, p=0.28). Frequency of hospitalisations and outpatient visits per patient declined after the first year. All-cause secondary care costs in the first year were SEK 122 758 (€12 890)/patient/year, with HF-specific care accounting for 69% of the costs. Overall, 10% of the most expensive population (younger; predominantly male; more likely to have comorbidities) incurred ~40% of total secondary care costs.ConclusionsHF-associated costs and HRU are high, especially during the first year of diagnosis. This is driven by high hospitalisations rates. Understanding the profile of resource-intensive patients being at younger age, male sex and high Charlson comorbidity index scores at the time of the HF diagnosis is most likely a sign of more severe disease. |
| وصف الملف: | application/pdf |
| اللغة: | English |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9a3acdab2052a09f5ab7c5ca94b335ba http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-189120 |
| Rights: | OPEN |
| رقم الانضمام: | edsair.doi.dedup.....9a3acdab2052a09f5ab7c5ca94b335ba |
| قاعدة البيانات: | OpenAIRE |
| الوصف غير متاح. |